CL
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Relationship between negative-pressure ICU rooms and the risk of COVID-19-associated pulmonary aspergillosis : an ancillary analysis of the COVID-ICU cohort study | Critical care |  | 2026 | 1 | 0 | ||
| Re : 'In vitro activity of cefepime-enmetazobactam on carbapenem-resistant gram negatives' by Bonnin et al | Clinical microbiology and infection |  | 2025 | 45 | 0 | ||
| Rapid detection of cefepime-taniborbactam susceptibility/resistance in Enterobacterales | International journal of antimicrobial agents | | 2025 | 25 | 172 | ||
| In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates | European journal of clinical microbiology & infectious diseases | | 2025 | 120 | 105 | ||
| Effect of hypnotic communication on pain during arterial blood gas standardized procedures in the emergency department compared with traditional communication : a triple-blind randomized controlled trial (POPAIN study) | European journal of emergency medicine | | 2025 | 12 | 273 | ||
| PEEP-AKI-COVID ICU : Effect of positive end-expiratory pressure on acute kidney injury development in patients with COVID-19-associated acute respiratory distress syndrome: an ancillary analysis of the COVID-ICU study | Journal of intensive care | | 2025 | 12 | 115 | ||
| Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations | Antimicrobial agents and chemotherapy | | 2025 | 19 | 22 | ||
| The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam | Antimicrobial agents and chemotherapy | | 2025 | 33 | 33 | ||
| Inhibitory activity of meso-dimercaptosuccinic acid against IMP metallo-β-lactamase variants in Pseudomonas aeruginosa | FEMS microbiology letters | | 2025 | 24 | 87 | ||
| Management of Invasive Pulmonary Aspergillosis in Intensive Care Units : Guidelines From the Fungal Infection Network of Switzerland (FUNGINOS) | Mycoses | | 2025 | 11 | 433 | ||
| Re: Potent in vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates : author's response | Clinical microbiology and infection | | 2025 | 27 | 0 | ||
| Effect of modification of penicillin-binding protein 3 on susceptibility to ceftazidime-avibactam, imipenem-relebactam, meropenem-vaborbactam, aztreonam-avibactam, cefepime-taniborbactam, and cefiderocol of Escherichia coli strains producing broad-spectrum β-lactamases | Antimicrobial agents and chemotherapy | | 2024 | 59 | 253 | ||
| SAFEty assessment of a REdirection process after TRIage (SAFE RETRI) by a triage nurse in an emergency department : a monocentric cohort study | Swiss medical weekly | | 2024 | 53 | 110 | ||
| In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022 | European journal of clinical microbiology & infectious diseases | | 2024 | 61 | 181 | ||
| Impact of extended-spectrum chromosomal AmpC (ESAC) of Escherichia coli on susceptibility to cefiderocol | Microbiology spectrum | | 2024 | 78 | 152 | ||
| Early reduction in gut microbiota diversity in critically ill patients is associated with mortality | Annals of intensive care | | 2024 | 39 | 154 | ||
| Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor taniborbactam against metallo-β-lactamases | Antimicrobial agents and chemotherapy | | 2024 | 59 | 201 | ||
| Multidrug-resistant Gram-negative clinical isolates with reduced susceptibility/resistance to cefiderocol : which are the best present and future therapeutic alternatives ? | European journal of clinical microbiology & infectious diseases | | 2024 | 47 | 129 | ||
| Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates | Clinical microbiology and infection | | 2024 | 113 | 1 | ||
| Impact of intensive prone position therapy on outcomes in intubated patients with ARDS related to COVID-19 | Annals of intensive care | | 2024 | 86 | 359 | ||
| Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases | Antimicrobial agents and chemotherapy | | 2024 | 72 | 198 | ||
| Reduced susceptibility to aztreonam-avibactam conferred by acquired AmpC-type β-lactamases in PBP3-modified Escherichia coli | European journal of clinical microbiology & infectious diseases | | 2024 | 41 | 0 | ||
| Ventilator-associated pneumonia related to extended-spectrum beta-lactamase producing Enterobacterales during severe acute respiratory syndrome coronavirus 2 infection : risk factors and prognosis | Critical care | | 2024 | 72 | 351 | ||
| Flow dynamics | Scandinavian journal of trauma, resuscitation and emergency medicine | | 2024 | 47 | 141 | ||
| Pulmonary embolism impacts clinical outcomes of intubated patients with acute respiratory distress syndrome related to COVID-19 | Anaesthesia critical care & pain medicine | | 2024 | 109 | 138 | ||
| Relative inhibitory activities of the broad-spectrum β-lactamase inhibitor xeruborbactam in comparison with taniborbactam against metallo-β-lactamases produced in Escherichia coli and Pseudomonas aeruginosa | Antimicrobial agents and chemotherapy | | 2024 | 60 | 36 | ||
| Structural basis of metallo-β-lactamase resistance to taniborbactam | Antimicrobial agents and chemotherapy | | 2024 | 66 | 62 | ||
| NDM-9 resistance to taniborbactam | Lancet. Infectious diseases | | 2023 | 41 | 34 | ||
| Wide dissemination of Gram-negative bacteria producing the taniborbactam-resistant NDM-9 variant : a One Health concern | The journal of antimicrobial chemotherapy | | 2023 | 240 | 310 | ||
| In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates | The journal of antimicrobial chemotherapy | | 2023 | 37 | 101 | ||
| No waiting lying in a corridor : a quality improvement initiative in an emergency department | BMJ open quality | | 2023 | 69 | 136 | ||
| Anaesthetic and peri-operative management for thrombectomy procedures in stroke patients | Anaesthesia critical care & pain medicine | | 2023 | 33 | 0 | ||
| Association of Trace Element Levels with Outcomes in Critically Ill COVID-19 Patients | Nutrients | | 2023 | 701 | 789 | ||
| Bleeding on oral anticoagulants : overview of reversal strategies | Swiss medical weekly | | 2023 | 64 | 172 | ||
| The Effect of Positive Therapeutic Communication on Pain (POPAIN) and Anxiety During Arterial Blood Gas Standardized Procedures in the Emergency Department Compared to Traditional Communication : Protocol for a Monocentric Randomized Controlled Trial | JMIR research protocols | | 2023 | 51 | 263 | ||
| Limitation of life-sustaining therapies in critically ill patients with COVID-19 : a descriptive epidemiological investigation from the COVID-ICU study | Critical care | | 2023 | 97 | 554 | ||
| Impact of acquired broad-spectrum β-lactamases on susceptibility to oral penems/carbapenems (tebipenem, sulopenem, and faropenem) alone or in combination with avibactam and taniborbactam β-lactamase inhibitors in Escherichia coli | Antimicrobial agents and chemotherapy | | 2023 | 58 | 113 | ||
| Galère des jeunes médecins : « Less is more » ? | Revue médicale suisse | | 2023 | 44 | 42 | ||
| Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa | Antimicrobial agents and chemotherapy | | 2023 | 66 | 130 | ||
| In vitro activity of aztreonam in combination with newly developed β-lactamase inhibitors against MDR enterobacterales and Pseudomonas aeruginosa producing metallo-β-lactamases | The journal of antimicrobial chemotherapy | | 2023 | 82 | 114 | ||
| The central and biodynamic role of gut microbiota in critically ill patients | Critical care | | 2022 | 155 | 283 | ||
| Is the prognosis of non-hypertensive, COVID-19 patients treated with renin-angiotensin-aldosterone system inhibitors more uncertain? | Physiological reports | | 2022 | 145 | 122 | ||
| Early measurement of ROX index in intermediary care unit is associated with mortality in intubated COVID-19 patients : a retrospective study | Journal of clinical medicine | | 2022 | 114 | 164 | ||
| Unsupervised clustering reveals phenotypes of AKI in ICU COVID-19 patients | Frontiers in medicine | | 2022 | 39 | 101 | ||
| Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19 : An Emulated Target Trial Analysis | American journal of respiratory and critical care medicine | | 2022 | 51 | 411 | ||
| Blood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective | Journal of clinical medicine | | 2022 | 43 | 507 | ||
| Emergency endotracheal intubation : best practice versus reality | Swiss medical weekly | | 2022 | 47 | 113 | ||
| A pilot clinical and radiographic study on the association between periodontitis and serious COVID‐19 infection | Clinical and experimental dental research | | 2022 | 275 | 631 | ||
| Delayed intubation is associated with mortality in patients with severe COVID-19: A single-centre observational study in Switzerland | Anaesthesia critical care & pain medicine | | 2022 | 731 | 858 | ||
| Management and outcomes of pregnant women admitted to intensive care unit for severe pneumonia related to SARS-CoV-2 infection : the multicenter and international COVIDPREG study | Intensive care medicine | | 2022 | 64 | 119 | ||
| Early prone positioning in acute respiratory distress syndrome related to COVID-19: a propensity score analysis from the multicentric cohort COVID-ICU network-the ProneCOVID study | Critical care | | 2022 | 133 | 501 | ||
| Implementation of a Novel Concept of Emergency Department Management : e-Boss | International journal of environmental research and public health | | 2022 | 60 | 28 | ||
| Complications des dérivations ventriculaires internes | Revue médicale suisse | | 2022 | 71 | 1,454 | ||
| Predicting 90-day survival of patients with COVID-19 : Survival of Severely Ill COVID (SOSIC) scores | Annals of intensive care | | 2021 | 66 | 74 | ||
| SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 385 | 38 | |||
| Impact of a restrictive antibiotic policy on the acquisition of extended-spectrum beta-lactamase-producing Enterobacteriaceae in an endemic region: a before-and-after, propensity-matched cohort study in a Caribbean intensive care unit | Critical care | | 2021 | 231 | 283 | ||
| Benefits and risks of noninvasive oxygenation strategy in COVID-19 : a multicenter, prospective cohort study (COVID-ICU) in 137 hospitals | Critical care | | 2021 | 53 | 371 | ||
| Characteristics, management, and prognosis of elderly patients with COVID-19 admitted in the ICU during the first wave : insights from the COVID-ICU study : Prognosis of COVID-19 elderly critically ill patients in the ICU | Annals of intensive care | | 2021 | 524 | 880 | ||
| Fatal Multiorgan Failure Syndrome in a Strongyloides-HTLV-1 Coinfected Patient, after Treatment with Ivermectin | Case reports in critical care | | 2021 | 41 | 152 | ||
| SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | | 2021 | 426 | 278 | ||
| Characteristics and prognosis of bloodstream infection in patients with COVID-19 admitted in the ICU : an ancillary study of the COVID-ICU study | Annals of intensive care | | 2021 | 55 | 298 | ||
| Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study | Intensive care medicine | | 2021 | 361 | 244 | ||
| Mental health of adolescent relatives of intensive care patients : benefits of an open visitation policy | American journal of critical care | | 2021 | 32 | 0 | ||
| Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study | Clinical Nutrition | | 2021 | 851 | 709 | ||
| Wide spread of carbapenemase-producing bacterial isolates in a Nigerian environment | Journal of global antimicrobial resistance | | 2020 | 24 | 34 | ||
| Preparedness and reorganization of care for coronavirus disease 2019 patients in a swiss ICU : characteristics and outcomes of 129 patients | Critical Care Exploration | | 2020 | 635 | 264 | ||
| Severe malaria : a micro vessel disease | Intensive care medicine | | 2020 | 27 | 0 | ||
| Prevalence of Anxiety and Depression Symptomatology in Adolescents Faced With the Hospitalization of a Loved One in the ICU | Critical care medicine | | 2018 | 57 | 0 | ||
| A giant compressive non coronary Valsalva sinus aneurysm | European heart journal | | 2017 | 25 | 0 |
